세계의 단위 용량 포장 시장 예측(-2030년) : 제품별, 재료별, 유통 채널별, 용도별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Unit Dose Packaging Market is accounted for $30.52 billion in 2024 and is expected to reach $45.29 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Unit dose packaging refers to a method of packaging pharmaceuticals or other products where each dose is individually packaged in a single-use container. This system ensures accurate dosing, minimizes the risk of contamination, and enhances patient safety by preventing misuse or accidental overdose. Typically used in healthcare settings, unit dose packaging simplifies administration and helps with inventory management. Each unit dose is pre-measured and labeled, making it easier for healthcare providers to track medication and ensure compliance with prescribed treatments.

According to the report published in June 2021 by the India Brand Equity Foundation (IBEF), the Indian pharmaceutical sector supplies more than 50% of the global demand for various vaccines, 40% of the generic demand in the U.S., and over 25% of total medicines in the U.K.

Market Dynamics:

Driver:

Rising chronic diseases

Chronic conditions often require long-term, consistent treatment regimens, making accurate dosing essential for effective management. Unit dose packaging ensures that patients receive the correct dose every time, reducing the risk of medication errors and improving adherence. This packaging format is particularly beneficial for elderly and chronically ill patients, who may struggle with complex medication schedules, thus enhancing their safety and convenience. As chronic diseases become more common, the demand for unit dose packaging continues to grow.

Restraint:

Regulatory hurdles

Unit dose packaging faces regulatory hurdles due to stringent requirements for safety, efficacy, and quality control, which vary by region and country. These regulations mandate rigorous testing, documentation, and compliance with standards, making the development and approval process complex and costly. Such regulatory challenges can delay product launches, increase production costs, and restrict market entry for new players. Consequently, these factors can hamper market growth by limiting the pace of innovation and increasing the financial burden on manufacturers.

Opportunity:

Growth in healthcare facilities

The growth in healthcare facilities, including hospitals, clinics, and long-term care centers, increases the demand for efficient and safe medication distribution systems. As more facilities are established, the need for precise, ready-to-administer medication doses rises, driving the adoption of unit dose packaging. This packaging method supports streamlined operations, reduces medication errors, and enhances patient safety, making it essential in expanding healthcare settings.

Threat:

High production costs

Unit dose packaging incurs high production costs due to the complexity of designing and manufacturing individual containers, precise dosing mechanisms, and quality control measures. The specialized materials and technologies required, such as barrier films and tamper-evident seals, contribute to increased expenses. These higher costs can impact overall profitability and pricing, making unit dose packaging less attractive compared to bulk alternatives. Consequently, the elevated production costs can limit market adoption, especially in cost-sensitive regions, and hinder the growth of the unit dose packaging market.

Covid-19 Impact

The covid-19 pandemic heightened the demand for unit dose packaging due to its role in improving safety and reducing cross-contamination risks. The need for precise medication dosing and infection control drove healthcare facilities to adopt unit dose systems more widely. However, supply chain disruptions and increased costs of raw materials posed challenges. The pandemic also accelerated trends towards automation and digital solutions in packaging to manage high volumes and ensure efficient distribution of medications.

The pre-filled syringes segment is expected to be the largest during the forecast period

The pre-filled syringes segment is estimated to be the largest during the forecast period. Pre-filled syringes in unit dose packaging offer a convenient and precise solution for medication administration. Each syringe is pre-measured with a single dose of medication, reducing the risk of dosing errors and contamination. This packaging method improves efficiency in healthcare settings by streamlining the administration process and enhancing patient safety. It is particularly valuable for biologics, vaccines, and chronic condition treatments, ensuring accurate dosing and ease of use for both healthcare providers and patients.

The biologics segment is expected to have the highest CAGR during the forecast period

The biologics segment is anticipated to witness the highest CAGR growth during the forecast period. Unit dose packaging in biologics ensures precise and safe administration of complex medications. This packaging method provides single-use containers for each dose, minimizing contamination risks and dosing errors. It is particularly beneficial for biologics, which often require stringent handling and accurate dosing due to their sensitive nature. By streamlining preparation and reducing the risk of cross-contamination, unit dose packaging enhances patient safety and adherence while improving efficiency in healthcare settings.

Region with largest share:

In the Asia-Pacific region, the unit dose packaging market is expanding rapidly and is anticipated to register the largest market share due to increasing healthcare infrastructure, a rising focus on patient safety, and growing chronic disease prevalence. The region's diverse pharmaceutical industry drives demand for efficient and precise medication delivery systems. Innovations in packaging technology and regulatory advancements further support market growth. Additionally, the expansion of hospitals, clinics, and long-term care facilities boosts the need for unit dose solutions, enhancing medication management and patient care across various countries in the region.

Region with highest CAGR:

In North America, the unit dose packaging market is experiencing significant growth driven by a strong focus on patient safety, regulatory requirements, and technological advancements. The region's robust healthcare infrastructure and high prevalence of chronic diseases increase demand for precise and efficient medication management systems. Innovations in packaging technology and a growing emphasis on reducing medication errors support market expansion. Additionally, the rise in healthcare facilities and the push for improved inventory management and medication adherence further contribute to the market's growth in North America.

Key players in the market

Some of the key players profiled in the Unit Dose Packaging Market include BD (Becton, Dickinson and Company), Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, MediSafe, Omnicare Inc., AccuStar Packaging, Schaefer Technologies Inc., Pharmapack, Paragon Healthcare, Lonza, Trellis Pharma, Systech International, Vetter Pharma-Fertigung GmbH & Co. KG, Uhlmann Pac-Systeme GmbH & Co. KG and Jones Healthcare.

Key Developments:

In September 2022, BD (Becton, Dickinson and Company) introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity. The new BD EffivaxTM Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.

In August 2022, Jones Healthcare Launched Sustainable FlexRx(TM) one blister pack, designed for automation. The new unit-dose adherence package is ideal for retail, specialty and long-term care pharmacies using centralized fulfillment or automation in-house. This bioplastic is manufactured from renewable resources, is free of any chemicals of concern, and is also readily recyclable across most households in North America.

Products Covered:

• Blister Packs
• Vials
• Ampoules
• Pre-filled Syringes
• Pouches
• Bottles
• Other Products

Materials Covered:

• Plastic
• Paperboard
• Glass
• Metal
• Other Materials

Distribution Channels Covered:

• Direct Sales
• Online Sales
• Third-Party Distributors
• Other Distribution Channels

Applications Covered:

• Biologics
• Over-the-Counter (OTC) Medications
• Nutraceuticals
• Other Applications

End Users Covered:

• Hospitals
• Long-Term Care Facilities
• Home Care Settings
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Unit Dose Packaging Market, By Product

• 5.1 Introduction
• 5.2 Blister Packs
• 5.3 Vials
• 5.4 Ampoules
• 5.5 Pre-filled Syringes
• 5.6 Pouches
• 5.7 Bottles
• 5.8 Other Products

6 Global Unit Dose Packaging Market, By Material

• 6.1 Introduction
• 6.2 Plastic
• 6.3 Paperboard
• 6.4 Glass
• 6.5 Metal
• 6.6 Other Materials

7 Global Unit Dose Packaging Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Direct Sales
• 7.3 Online Sales
• 7.4 Third-Party Distributors
• 7.5 Other Distribution Channels

8 Global Unit Dose Packaging Market, By Application

• 8.1 Introduction
• 8.2 Biologics
• 8.3 Over-the-Counter (OTC) Medications
• 8.4 Nutraceuticals
• 8.5 Other Applications

9 Global Unit Dose Packaging Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Long-Term Care Facilities
• 9.4 Home Care Settings
• 9.5 Other End Users

10 Global Unit Dose Packaging Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 BD (Becton, Dickinson and Company)
• 12.2 Gerresheimer AG
• 12.3 West Pharmaceutical Services Inc.
• 12.4 Nemera
• 12.5 MediSafe
• 12.6 Omnicare Inc.
• 12.7 AccuStar Packaging
• 12.8 Schaefer Technologies Inc.
• 12.9 Pharmapack
• 12.10 Paragon Healthcare
• 12.11 Lonza
• 12.12 Trellis Pharma
• 12.13 Systech International
• 12.14 Vetter Pharma-Fertigung GmbH & Co. KG
• 12.15 Uhlmann Pac-Systeme GmbH & Co. KG
• 12.16 Jones Healthcare